Search

Your search keyword '"Martinelli E"' showing total 2,075 results

Search Constraints

Start Over You searched for: Author "Martinelli E" Remove constraint Author: "Martinelli E"
2,075 results on '"Martinelli E"'

Search Results

102. O-7 Evidence of therapeutic effectiveness of third-line cetuximab rechallenge in appropriately selected patients: Findings from long-term follow-up of CRICKET and CAVE trials

103. P-68 Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): An academic, multicenter, single-arm, two-stage, phase 2 study

105. Corrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

110. Valorisation of Crocus sativus flower parts for herbal infusions: impact of brewing conditions on phenolic profiling, antioxidant capacity and sensory traits

111. Phytochemical profiling, antibacterial and antioxidant properties of Crocus sativus flower: A comparison between tepals and stigmas

112. C. spinosa L. subsp. rupestris Phytochemical Profile and Effect on Oxidative Stress in Normal and Cancer Cells

113. An explainable model of host genetic interactions linked to COVID-19 severity

114. An explainable model of host genetic interactions linked to COVID-19 severity

116. Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo

117. 163P Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: Findings from the CAVE-lung trial

122. Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women

124. Urinary and sexual outcomes after water vapour intraprostatic injection (Rezum procedure): Results from prospective multicentric Italian study

127. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer

129. Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

131. AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer

135. 445P Tumor load surrogates as major prognostic factors in BRAF-V600E mutated (mt) colorectal (CRC) patients treated with BRAF inhibitor+antiEGFR +/- MEK inhibitor

141. LBA-3 Integrated analysis of cell-free DNA (cfDNA) BRAF mutant allele fraction (MAF) and whole exome sequencing in BRAFV600E metastatic colorectal cancer (mCRC) treated with BRAF-antiEGFR +/- MEK inhibitors

143. P-199 Baseline neutrophil to lymphocyte ratio predicts survival in patients with metastatic colorectal cancer treated with cetuximab plus avelumab (CAVE) as a rechallenge strategy

147. Comparative in vitro antioxidant capacity and terpenoid profiling of pumpkin fruit pulps from a Serbian cucurbita maxima and cucurbita moschata breeding collection

148. Current perspectives in cell-based approaches towards the definition of the antioxidant activity in food

149. Bee products: A representation of biodiversity, sustainability, and health

150. Antioxidant properties of bee products derived from medicinal plants as beekeeping sources

Catalog

Books, media, physical & digital resources